Navigation Links
Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010

NEW BRUNSWICK, N.J., Sept. 15 /PRNewswire/ -- On Sept. 23 and 24, the Hyatt Regency in New Brunswick, N.J. will host Contracting & Outsourcing 2010, the 9th annual Conference and Tabletop Exhibition held by Contract Pharma Magazine. This year's Conference will feature a keynote presentation by Mac Lynch, Vice President, Contract Manufacturing at Pfizer, covering Global Pharma Outsourcing Trends. Other speakers and panelists represent FDA, Johnson & Johnson, Roche/Genentech, Bristol-Myers Squibb, Merck, GlaxoSmithKline and more.

Contracting & Outsourcing 2010 will feature presentations and panels discussing a wide array of pharma and biopharma outsourcing and contract service topics, including far east outsourcing, sponsor-provider partnerships, CMO management, FDA compliance enforcement, clinical trial management, inspection issues and more. The conference will also include a panel on Contract Laboratory Criteria and the inaugural Executive Outsourcing Summit, with participants from across the drug development spectrum.

The event will feature a one-day Tabletop Exhibition on Sept. 23. With 160 contract service providers and vendors in attendance, the Exhibit Hall will cover virtually every aspect of the drug development and commercialization continuum.

Networking opportunities are enhanced by a Cocktail Reception at the end of the first day. Sponsored by Catalent Pharma Solutions, the reception offers an informal atmosphere for conversation and deal-making. The mix of presentations and exhibitions promises value to attendees from large pharma and biopharma companies as well as those from emerging and startup firms.

A full list of exhibitors can be found at

The schedule for Contracting & Outsourcing, as well as bios of all speakers, can be found at

Attendee registration costs $395 and covers all conference and exhibit hall  sessions, lunch, refreshment breaks, and the Networking Reception. Registration is available online at or by walkup at the Hyatt Regency in New Brunswick, NJ.

Now in its ninth year, Contracting & Outsourcing is the premier event for pharma and biopharma contract services and outsourcing.

For additional information about Contracting & Outsourcing 2010, visit or contact Kristin Brooks at +1-201-880-2226 or For more about Contract Pharma, the top magazine worldwide for pharma and biopharma contract services and outsourcing, visit

SOURCE Contract Pharma Magazine
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. WWMR Announces Pain Clinic Physicians Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals
2. Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member
3. Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors
4. Neuralstem CEO to Speak on ALS Panel at World Stem Cell Summit
5. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
6. MedNet Solutions to Speak, Sponsor and Exhibit at the 2008 Society of Clinical Data Management Annual Conference in Dallas
7. Former Speaker of the House Newt Gingrich Featured Wednesday
8. Brain and Hearing Pioneer, Michael Merzenich, Ph.D. to Speak at Case Western Reserve University
9. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
10. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
11. Varian, Inc. CEO to Speak at the Nasdaq OMX 22nd Investor Program
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015  Twist Bioscience, ... that Emily Leproust, Ph.D., Twist Bioscience chief executive ... Healthcare Conference on December 1, 2015 at 3:10 ... in New York City. --> ... . Twist Bioscience is on Twitter. Sign ...
(Date:11/24/2015)... BC (PRWEB) , ... November 24, 2015 , ... ... our customer, OrthoAccel® Technologies, Inc., on being named to Deloitte's 2015 Technology Fast ... Technologies’ Texas facility, OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that ...
(Date:11/24/2015)... HemoShear Therapeutics, LLC, a privately held ... disorders, announced today the appointment of H. ... (BOD). Mr. Watkins is the former president and ... and also served as the chairman of the ... Chairman and CEO of HemoShear Therapeutics. "The combination ...
(Date:11/24/2015)... ... ... Laboratories is pleased to announce that it has completed construction on a new ... 61, USP 62 and USP 51 testing specific to raw materials and will enable ... by one supplier. Management has formally announced that the facility will be ...
Breaking Biology Technology:
(Date:11/19/2015)... -- Although some 350 companies are actively involved in molecular ... according to Kalorama Information. These include Roche Diagnostics, Hologic, Abbott ... of the 6.1 billion-dollar molecular testing market, according to ... Diagnostic s .    ... one company and only a handful of companies can ...
(Date:11/17/2015)... , November 17, 2015 ... 19 novembre  2015.  --> Paris , ... --> DERMALOG, le leader de l,innovation biométrique, a ... fois passeports et empreintes sur la même surface de ... passeports et l,autre pour les empreintes digitales. Désormais, un ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
Breaking Biology News(10 mins):